PTCT – ptc therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PTCT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

2/23

11:16 am

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

2/23

11:16 am

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

2/23

08:03 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

2/23

08:03 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

2/23

07:01 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Barclays PLC.

Report

2/20

03:14 pm

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.

Report

2/20

12:54 pm

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

2/20

12:54 pm

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

2/20

09:42 am

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

2/20

09:42 am

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

2/20

09:03 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

2/20

09:03 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "sector perform" rating reaffirmed by analysts at Royal Bank Of Canada.

Report

1/28

09:46 am

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

1/28

09:46 am

ptct

Rating for PTCT

Low Report

Rating for PTCT

Report

1/27

06:00 pm

ptct

PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.

Low Report

PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.

Report

1/8

08:02 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

1/8

08:02 am

ptct

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Low Report

PTC Therapeutics (NASDAQ:PTCT) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.